A 2021 micro-costing Netherlands model for lifetime hospital costs for advanced BC found an average cost of € 52,709 (C$ 77,482) ranging from € 29,803 (C$ 43,810) in TN to € 92,272 (C$ 135,639) in HR+/HER2+ BC [57]. This evidence concerns the gene ERBB2 and breast cancer.